Edition:
United Kingdom

Corvus Pharmaceuticals Inc (CRVS.OQ)

CRVS.OQ on NASDAQ Stock Exchange Global Market

3.42USD
24 Jun 2019
Change (% chg)

$-0.00 (-0.00%)
Prev Close
$3.42
Open
$3.37
Day's High
$3.45
Day's Low
$3.35
Volume
14,594
Avg. Vol
19,698
52-wk High
$12.47
52-wk Low
$3.22

About

Corvus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of immuno-oncology therapies. The Company is developing drugs and antibodies that block crucial immune checkpoints and reprogram immune T-cells. The Company has a pipeline of four immuno-onc... (more)

Overall

Beta: --
Market Cap(Mil.): $348.98
Shares Outstanding(Mil.): 20.93
Dividend: --
Yield (%): --

Financials

  CRVS.OQ Industry Sector
P/E (TTM): -- 69.29 32.55
EPS (TTM): -2.58 -- --
ROI: -40.42 8.90 13.82
ROE: -40.82 10.04 15.24

Earnings vs. Estimates